Molecular mechanisms underlying the effects of cyclosporin A and sirolimus on glucose and lipid metabolism in liver, skeletal muscle and adipose tissue in an in vivo rat model-Reference-Cited by-同舟云学术

Molecular mechanisms underlying the effects of cyclosporin A and sirolimus on glucose and lipid metabolism in liver, skeletal muscle and adipose tissue in an in vivo rat model

Published:2014-03 Issue:2 Volume:88 Page:216-228
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Fuhrmann A.,Lopes PC.,Sereno J.,Pedro J.,Espinoza D.O.,Pereira M.J.,Reis F.,Eriksson J.W.,Carvalho E.

Funder

European Foundation for the Study of Diabetes (EFSD) Albert Renold Fellowship 2012 – 94728 (AF)

SFRH/BD/63962/2009

PTDC/SAU-OSM/104124/2008

PEST – C/SAU/LAOOO1/2011

FEDER funds and the GIFT/Sociedade Portuguesa de Diabetologia

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference57 articles.

1. Current immunosuppressive agents: efficacy, side effects, and utilization;Smith;Pediatr Clin North Am,2003

2. New-onset diabetes mellitus after solid organ transplantation;Bodziak;Traspl Int,2009

3. Predicting, managing and preventing new-onset diabetes after transplantation;Gosmanov;Minerva Endocrinol,2012

4. Correlation between lipid abnormalities and immunosuppressive therapy in renal transplant recipients with stable renal function;Perrea;Int Urol Nephrol,2008

5. Dyslipidemia following kidney transplantation: diagnosis and treatment;Badiou;Curr Diab Rep,2009

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Could the administration of SGLT2i agents serve as a viable prophylactic approach against CNI-induced toxicities?;Medical Hypotheses;2024-08

2. Time-course cross-species transcriptomics reveals conserved hepatotoxicity pathways induced by repeated administration of cyclosporine A;Toxicology Mechanisms and Methods;2024-06-27

3. A lipid index for risk of hyperlipidemia caused by anti-retroviral drugs;Antiviral Research;2024-03

4. Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host disease;Bone Marrow Transplantation;2023-09-08

5. A mixed blessing for liver transplantation patients — Rapamycin;Hepatobiliary & Pancreatic Diseases International;2023-02